ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

49,949Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 6645

$3.68M Total Retail Price of All Prescriptions

Rank: 16 out of 6645

989 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 989 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 49,065 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

44% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

51 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
NEXIUM 2,272 2,247 10 1 40
SIMVASTATIN 2,035 1,965 2 1
AMLODIPINE BESYLATE 1,687 1,616 3 2
CREON 1,220 1,216 10 4 114
ALENDRONATE SODIUM 1,213 1,202 5 14
ATORVASTATIN CALCIUM 1,211 1,205 6 10
LEVOFLOXACIN 1,147 1,120 10 7 83
CELEBREX 1,143 1,138 8 54
DIOVAN HCT 1,127 1,112 10 9 64
LOSARTAN-HYDROCHLOROTHIAZIDE 1,102 1,102 10 62
EVISTA 985 979 11 90
DONEPEZIL HCL 962 962 12 27
OMEPRAZOLE 946 902 13 6
LIDODERM 926 917 14 53
TAMSULOSIN HCL 820 812 15 22
GABAPENTIN 784 771 16 18
ATENOLOL 721 697 17 8
ZOLPIDEM TARTRATE 623 622 18 17
JANUMET 595 580 19 132
ACTONEL 559 559 20 92
LOSARTAN POTASSIUM 544 531 21 12
LEVOTHYROXINE SODIUM 538 538 22 4
METOPROLOL TARTRATE 532 510 23 13
METFORMIN HCL 527 526 24 7
CLOPIDOGREL 488 479 25 36
DIOVAN 485 485 26 19
FAMOTIDINE 478 478 27 33
ALBUTEROL SULFATE 478 464 27 112
POTASSIUM CHLORIDE 477 476 29 28
KLOR-CON 8 475 465 10 30 123
MELOXICAM 468 454 31 46
METFORMIN HCL ER 464 454 32 89
GLYBURIDE-METFORMIN HCL 460 426 R 33 95
AVODART 455 443 34 99
FUROSEMIDE 423 423 35 11
TRAMADOL HCL 422 422 36 30
SINGULAIR 399 399 37 76
MEGESTROL ACETATE 392 392 R 10 38 104
JANUVIA 391 378 39 38
SUCRALFATE 385 370 40 256
PLAVIX 372 360 41 49
DEXILANT 370 356 42 102
TRIAMCINOLONE ACETONIDE 369 364 43 55
DOXAZOSIN MESYLATE 367 361 44 81
AMOX TR-POTASSIUM CLAVULANATE 355 351 10 45 185
SERTRALINE HCL 343 343 46 43
HYDROCODONE-ACETAMINOPHEN 337 329 S3 47 5
IBANDRONATE SODIUM 331 331 10 48 147
BENAZEPRIL HCL 300 300 49 21
TRIAMTERENE-HCTZ 299 285 50 52
PRAVASTATIN SODIUM 296 292 51 20
BENICAR HCT 274 257 52 158
POLYETHYLENE GLYCOL 3350 244 243 53 121
METOPROLOL SUCCINATE 240 240 54 24
BONIVA 239 239 55 191
ISOSORBIDE MONONITRATE ER 237 224 56 66
PANTOPRAZOLE SODIUM 237 235 56 29
LIPITOR 229 229 58 69
MONTELUKAST SODIUM 226 226 59 128
NAMENDA 219 219 60 41
AZOR 216 216 61 152
AMLODIPINE BESYLATE-BENAZEPRIL 202 178 62 97
GLYBURIDE 201 199 R 63 58
METOCLOPRAMIDE HCL 197 197 64 120
LANSOPRAZOLE 191 191 65 163
VOLTAREN 190 190 66 108
CARVEDILOL 190 185 66 25
IBUPROFEN 189 188 68 42
ACTOS 185 185 69 71
EXFORGE 174 171 70 155
ESCITALOPRAM OXALATE 169 169 71 86
LANTUS 167 153 72 50
BUMETANIDE 167 167 72 267
ECONAZOLE NITRATE 159 157 74 263
AZITHROMYCIN 158 156 75 44
LYRICA 156 145 76 127
ALLOPURINOL 155 155 77 31
CARBIDOPA-LEVODOPA 152 152 78 116
NITROFURANTOIN MONO-MACRO 152 151 78 233
NORTRIPTYLINE HCL 149 143 80 171
VALSARTAN-HYDROCHLOROTHIAZIDE 145 143 10 81 314
LANTUS SOLOSTAR 143 140 82 139
ACETAMINOPHEN-CODEINE 142 141 S3 83 80
CRESTOR 138 138 84 34
AMOXICILLIN 137 130 85 107
HYDROXYZINE HCL 136 136 R 86 161
WARFARIN SODIUM 135 135 87 16
GEMFIBROZIL 134 134 88 96
ADVAIR DISKUS 132 132 89 45
AMITIZA 128 128 90 245
BENAZEPRIL-HYDROCHLOROTHIAZIDE 125 125 91 181
SYNTHROID 124 124 92 79
CYMBALTA 122 112 93 78
BENICAR 121 121 94 84
GLIPIZIDE 120 113 95 23
FINASTERIDE 120 120 95 73
FLUOCINONIDE 120 120 95 130
VERAPAMIL ER 118 118 98 154
NIFEDIPINE ER 113 113 99 82
NIFEDICAL XL 113 113 99 295
TRICOR 112 111 101 138
ADACEL 105 104 102 212
LOVAZA 102 102 103 68
ACIPHEX 100 100 104 167
VENLAFAXINE HCL ER 99 99 105 175
LUNESTA 98 98 106 287
MECLIZINE HCL 97 97 107 122
SPIRIVA 97 97 107 65
DICYCLOMINE HCL 95 95 109 278
VESICARE 89 87 110 148
GLIMEPIRIDE 88 88 111 47
CILOSTAZOL 87 87 112 202
DIGOXIN 87 87 112 59
PRAMIPEXOLE DIHYDROCHLORIDE 83 83 114 222
NASONEX 79 78 115 126
THEO-24 77 77 116 451
RANITIDINE HCL 77 65 116 51
FLUOXETINE HCL 76 76 118 63
ZOSTAVAX 74 70 119 115
PRIMIDONE 72 72 120 372
HYDROCHLOROTHIAZIDE 71 68 121 9
DIPHENOXYLATE-ATROPINE 70 69 122 214
LEXAPRO 70 70 122 218
MIRTAZAPINE 68 68 124 70
CEPHALEXIN 68 65 124 111
INSULIN SYRINGE 68 62 124 61
PIOGLITAZONE HCL 68 68 R 124 184
METOLAZONE 67 67 128 337
ZENPEP 65 65 129 210
ZETIA 65 65 129 87
PROAIR HFA 64 64 131 32
DESMOPRESSIN ACETATE 60 60 132 480
FLECTOR 59 59 133 230
CIPROFLOXACIN HCL 59 59 133 67
PREMARIN 56 54 R 135 169
CLOTRIMAZOLE 55 55 136 312
BENZTROPINE MESYLATE 55 55 R 136 188
LEVETIRACETAM 52 46 138 119
PROPYLTHIOURACIL 52 44 138 465
URSODIOL 51 51 140 349
DILTIAZEM 24HR CD 51 48 140 176
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 23, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.